The OND patients with an elevated antibody response to PLP in the top quartile of the OND group had a variety of CNS disorders, including epilepsy (3 patients), stroke (3 patients), and one each of CNS tumor and idiopathic intracranial hypertension. Here, PLP1 is linked to pseudotumor cerebri.